Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial.

Authors: Zilberman-Itskovich S, Catalogna M, Sasson E, Hadanny A, Lang E, Finci S et al.

PMID: 36261911 DOI: 10.1097/01.NAJ.0000897152.36663.7a

Abstract

According to this study: Hyperbaric oxygen therapy can improve cognitive function, psychiatric symptoms, pain, and fatigue in patients who have post-COVID-19 condition.The beneficial effect of the therapy can be attributed to increased brain perfusion and neuroplasticity in regions associated with cognitive and emotional roles.

Keywords: HBOT, hyperbaric oxygen therapy, neurocognitive, COVID-19

Source: https://pubmed.ncbi.nlm.nih.gov/36261911/
Archive: https://archive.is/L0O6C